Several studies [14, 15] have shown that routine screening for Cr-Ag in AIDS patients with CD4 + lymphocyte counts < 100 cells/μl and interventions for antigen-positive patients can reduce the morbidity and mortality of CM. This evidence concerns the gene CD4 and AIDS.